Arbutus Biopharma Corporation (ABUS) free cash flow

Free cash flow · fiscal 2025
-$39.64M

Arbutus Biopharma Corporation (ABUS) generated free cash flow of -$39.64M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$65.03M. Figures as of 18 Nov 2026, 12:06 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$39.64M
Highest on record
$32.89Mfiscal 2012
Lowest on record
-$86.94Mfiscal 2023
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arbutus Biopharma Corporation free cash flow, in more detail

Across the 15 fiscal years on record (2011–2025), the highest was $32.89M in fiscal 2012 and the lowest -$86.94M in fiscal 2023.

History · 15 fiscal years

Free cash flow by fiscal year

Arbutus Biopharma Corporation free cash flow, year by year

Arbutus Biopharma Corporation (ABUS) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$39.64M—
2024-$65.03M—
2023-$86.94M—
2022-$35.87M—
2021-$68.34M—
2020-$51.67M—
2019-$71.60M—
2018-$69.00M—
2017-$55.90M—
2016-$61.88M—
2015-$58.67M—
2014-$13.48M—
2013-$7.46M 122.7% down
2012$32.89M—
2011-$7.89M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on ABUS

Arbutus Biopharma Corporation, figure by figure

Arbutus Biopharma Corporation (ABUS) overview: price, valuation and scorecard

Arbutus Biopharma Corporation free cash flow: questions and answers

What is Arbutus Biopharma Corporation's free cash flow?

Arbutus Biopharma Corporation (ABUS) generated free cash flow of -$39.64M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$65.03M.

What are the highest and lowest free cash flow figures on record for Arbutus Biopharma Corporation?

Across the 15 fiscal years on record (2011–2025), the highest was $32.89M in fiscal 2012 and the lowest -$86.94M in fiscal 2023.

How is Arbutus Biopharma Corporation's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Arbutus Biopharma Corporation it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arbutus Biopharma Corporation (ABUS) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ABUS/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.